# Gyre Therapeutics Inc. (GYRE)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $532M  
**Price:** $5.95 (-2.94%)

> Gyre Therapeutics Inc. is a biotechnology firm dedicated to the discovery and development of innovative therapies for unmet medical needs. Its primary function is to leverage cutting-edge research and development technologies to address complex diseases and conditions that currently lack effective treatments. Gyre Therapeutics operates within the healthcare and biomedical sectors, impacting areas such as oncology, neurology, and rare genetic disorders. The company employs a robust pipeline strategy, focusing on both in-house R&D and collaborative partnerships to accelerate drug development and facilitate clinical trials. Through strategic alliances with academic institutions and pharmaceutical companies, Gyre Therapeutics aims to enhance its scientific capabilities and expand its therapeutic portfolio. As a specialized entity in the biotech industry, Gyre Therapeutics plays a crucial role in advancing medical science, potentially transforming patient care by bringing novel bio-pharmaceutical products to the market.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $117M | $111M | $11M | $10M | $0.02 |
| 2024 | $106M | $102M | $16M | $18M | $0.05 |
| 2023 | $113M | $109M | $19M | -$85M | $-1.41 |
| 2022 | $14M | $13M | $1M | $592,277 | $0.03 |
| 2021 | $12M | $12M | $4M | $3M | $0.31 |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $166M | $24M | $142M | $37M | $303,000 |
| 2024 | $125M | $27M | $98M | $12M | $885,000 |
| 2023 | $117M | $103M | $14M | $34M | $199,000 |
| 2022 | $12M | $2M | $10M | $3M | $16,612 |
| 2021 | $12M | $2M | $10M | $4M | $101,901 |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $3M | -$1M | -$913,000 |
| 2024 | $6M | -$2M | -$7M |
| 2023 | $7M | -$8M | $17M |
| 2022 | $122,942 | -$684,400 | $779,680 |
| 2021 | $4M | -$151,203 | $2M |

Source: [CompaniesByCap](https://companiesbycap.com/company/GYRE)